What is Tirzepatide?
Tirzepatide (also known as Mounjaro) (3rd generation GLP-1) possesses a unique dual mechanism of action, targeting both insulin and GLP-1 receptors. By efficiently regulating glucose level and promoting satiety, this groundbreaking medication propels remarkable weight loss results- 18% more weight loss than semaglutide.
- It directly reduces appetite and increases metabolism by action in the brain.
- It reduces glucagon secretion which is the hormone increasing hunger.
- It causes individuals to eat less carbs and fatty food.
- It increases insulin production, but only when blood sugar is high—which makes the risk of low blood sugar minimal.
- Decreases the liver’s production of sugar and increases uptake of sugar by muscle tissue.
- It slows down the speed at which the stomach empties food into the intestine. This produces weight loss and is also responsible for the gastrointestinal side effects.
